Aurora Spine Corp (OTCPK:ASAPF)

$ 0.2995 0.0045 (1.53%) Market Cap: 22.62 Mil Enterprise Value: 25.44 Mil PE Ratio: 0 PB Ratio: 4.77 GF Score: 36/100

Q3 2024 Aurora Spine Corp Earnings Call Transcript
Oct 28, 2024

$0.29 (-14.68%)

Earnings
Q2 2024 Aurora Spine Corp Earnings Call Transcript
Aug 23, 2024

$0.19815 (-4.83%)

Earnings
Q4 2023 and Q1 2024 Aurora Spine Corp Combined Earnings call Transcript
May 14, 2024

$0.19506 (-2.96%)

Earnings
Q2 2023 Aurora Spine Corp Earnings Call Transcript
Aug 29, 2023

$0.2002 (+5.37%)

Earnings
Q1 2023 Aurora Spine Corp Earnings Call Transcript
May 24, 2023

$0.21 (-13.22%)

Earnings
Q4 2022 Aurora Spine Corp Earnings Call Transcript
May 01, 2023

$0.2193 (+2.00%)

Earnings
Aurora Spine Corp at Precious Metals Summit Planet Microcap Showcase Transcript
Apr 26, 2023
Aurora Spine Corp at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 07, 2022
Q3 2022 Aurora Spine Corp Earnings Call Transcript
Nov 21, 2022

$0.36755 (-4.18%)

Earnings
Aurora Spine Corp at Lytham Partners Spring Investor Conference (Virtual) Transcript
Apr 04, 2022
Aurora Spine Corp at Lytham Partners Winter Investor Conference (Virtual) Transcript
Dec 13, 2021
Q3 2021 Aurora Spine Corp Earnings Call Transcript
Nov 16, 2021

$0.29 (+1.40%)

Earnings
Aurora Spine Corp at Lytham Partners Fall Investor Conference (Virtual) Transcript
Oct 05, 2021

Q4 2022 Aurora Spine Corp Earnings Call Transcript

May 01, 2023 / 04:00PM GMT

Release Date Price: $0.2193 (+2.00%)

Transcript

Operator

Good day, and welcome to the Aurora Spine reports fourth-quarter and fiscal-year 2022 financial results conference call. All participants will be in a listen-only mode. (Operator Instructions) Please note this event is being recorded.

I would now like to hand the conference over to Adam Lowensteiner with Lytham Partners. Please go ahead.

Adam Lowensteiner

Lytham Partners, LLC - IR

Thank you, Betsy. Welcome, everyone, and thank you all for joining us today to review the financial results for Aurora Spine for the fourth quarter and fiscal year ended December 31, 2022. With us on the call representing the company today are Trent Northcutt, President and CEO of Aurora Spine; and Chad Clouse, CFO of Aurora Spine.

Before we begin, I would like to remind everyone that statements made during the course of this call may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Act of 1934. These statements reflect current expectations concerning future events

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.